Evidence map›Paper›PMID 33513982›Full record

ArticleMarine drugs2021

Potential of Exopolysaccharide from

Nesrine Gargouch, Fatma Elleuch, Ines Karkouch, Olfa Tabbene, Chantal Pichon, Christine Gardarin, Christophe Rihouey, Luc Picton, Slim Abdelkafi, Imen Fendri and 1 more

Abstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Marine Compounds with Anti-Journal of fungi (Basel, Switzerland) · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nesrine GargouchInstitut Pascal, CNRS, SIGMA Clermont, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Fatma ElleuchCentre de Biophysique Moléculaire, CNRS-UPR 4301, 45071 Orléans, France.
Ines KarkouchLaboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria (CBBC), BP-901, Hammam-Lif 2050, Tunisia.
Olfa TabbeneLaboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria (CBBC), BP-901, Hammam-Lif 2050, Tunisia.
Chantal PichonCentre de Biophysique Moléculaire, CNRS-UPR 4301, 45071 Orléans, France.
Christine GardarinInstitut Pascal, CNRS, SIGMA Clermont, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Christophe RihoueyNormandie University, UNIROUEN, INSA Rouen, CNRS, PBS, 76000 Rouen, France.
Luc PictonNormandie University, UNIROUEN, INSA Rouen, CNRS, PBS, 76000 Rouen, France.
Slim AbdelkafiUnité de Biotechnologie des Algues, Biological Engineering Department, National School of Engineers of Sfax, University of Sfax, Sfax 3038, Tunisia.
Imen FendriLaboratoire de Biotechnologie Végétale Appliquée à l'Amélioration des Cultures, Faculty of Sciences of Sfax, University of Sfax, Sfax 3000, Tunisia.
Céline LarocheInstitut Pascal, CNRS, SIGMA Clermont, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exopolysaccharide (EPS) from marine microalgae are promising sources of a new generation of drugs. However, lot of them remain to be discovered and tested. In this study, EPS produced by

Indexed as

Breast NeoplasmsPorphyridiumAnimalsAnti-Bacterial AgentsBiofilmsCell Line, TumorCell SurvivalDose-Response Relationship, DrugFemaleMiceMicroalgaeMicrobial Sensitivity TestsPolysaccharides, BacterialAnti-Bacterial AgentsPolysaccharides, Bacterialantibacterial activityanti-biofilm activityanti-cancer activityexopolysaccharidehigh pressure homogenizerPorphyridium marinum

Identifiers

PMID33513982
PMCPMC7911520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.